Efficacy of ibrutinib in patients with chronic lymphocytic leukemia: A real-world experience
Latest Information Update: 19 Feb 2024
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2016 New trial record